Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.61 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | ARG2 | P78540 | 1/20 | 0.47 |
| ▸ | TOP1 | P11387 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | ADH1B | P00325 | 1/20 | 0.35 |
| ▸ | ADH1C | P00326 | 1/20 | 0.35 |
| ▸ | ADH1A | P07327 | 1/20 | 0.35 |
| ▸ | ADH7 | P40394 | 1/20 | 0.35 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 2/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL145088 | 1.00 | MAOB (0.61) | MAOBCA1CA2ARG2TOP1 | |
| SCHEMBL334261 | 1.00 | MAOB (0.61) | MAOBCA1CA2ARG2TOP1 | |
| SCHEMBL6803900 | 0.85 | MAOB (0.54) | MAOBCA1CA2ARG2TOP1 | |
| SCHEMBL6803903 | 0.85 | MAOB (0.54) | MAOBCA1CA2ARG2TOP1 | |
| SCHEMBL5254612 | 0.78 | GPR52 (0.50) | HCAR2 | |
| SCHEMBL146890 | 0.78 | GPR52 (0.50) | HCAR2 | |
| SCHEMBL2300477 | 0.78 | AGXT (0.39) | MAOBCA1CA2IDO1TP53 | |
| SCHEMBL10563302 | 0.77 | MAOB (0.61) | MAOBCA1CA2ARG2TOP1 | |
| SCHEMBL9718255 | 0.77 | MAOB (0.61) | MAOBCA1CA2ARG2TOP1 | |
| SCHEMBL155054 | 0.77 | MAOB (1.00) | MAOBCA1CA2ARG2TOP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9558863-B2 | Electrically conductive polymers with enhanced conductivity | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) | 2017-01-31 | — | — | US | disclosed |
| US-9243111-B2 | Water-soluble electrically conductive polymers | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) | 2016-01-26 | — | — | US | disclosed |
| US-20150083977-A1 | ELECTRICALLY CONDUCTIVE POLYMERS WITH ENHANCED CONDUCTIVITY | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) | 2015-03-26 | — | — | US | disclosed |
| US-8920681-B2 | Electrically conductive polymers with enhanced conductivity | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) | 2014-12-30 | — | — | US | disclosed |
| US-20140077135-A1 | WATER-SOLUBLE ELECTRICALLY CONDUCTIVE POLYMERS | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) | 2014-03-20 | — | — | US | disclosed |
| US-8536300-B2 | Photocrosslinkable electrically conductive polymers | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) | 2013-09-17 | — | — | US | disclosed |
| US-8535571-B2 | Water-soluble electrically conductive polymers | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) | 2013-09-17 | — | — | US | disclosed |
| US-8134023-B2 | Preparation of pregabalin and related compounds | PFIZER INC (US) | 2012-03-13 | — | — | US | disclosed |
| US-20120015412-A1 | Preparation of Pregabalin and Related Compounds | PFIZER INC | 2012-01-19 | — | — | US | disclosed |
| US-8044227-B2 | Preparation of pregabalin and related compounds | PFIZER INC. (US) | 2011-10-25 | — | — | US | disclosed |
| US-6110933-A | AN ENZYME INHIBITOR TREATING PANCREATITIS, HEPATITIS, CHRONIC RENAL FAILURE, ENDOTOXIN SHOCK, GRAM-NEGATIVE SEPTIC SHOCK, ARTHRITIS, RESPIRATORY DISEASE, HEART DISEASE, ALLERGIC DISEASE, THROMBOSIS, ARTERIOSCLEROSIS, PAIN | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-08-29 | — | — | US | disclosed |
| US-6096735-A | Benzoheterocyclic derivatives | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 2000-08-01 | — | — | US | disclosed |
| WO-2000000220-A1 | PHARMACEUTICAL COMPOSITION CONTAINING AN ESTER OR AMIDE PLA2 INHIBITOR | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-01-06 | — | — | WO | disclosed |
| EP-0741697-B1 | AMINO ACID DERIVATIVES AND THEIR USE AS PHOSPHOLIPASE A2 INHIBITORS | FUJISAWA PHARMACEUTICAL CO (JP) | 1999-09-15 | — | — | EP | disclosed |
| EP-0854863-A1 | ESTERS AND AMIDES AS PLA2 INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-07-29 | — | — | EP | disclosed |
| EP-0765314-A1 | BENZOHETEROCYCLIC DERIVATIVES USEFUL AS VASOPRESSIN OR OXYTOCIN MODULATORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1997-04-02 | — | — | EP | disclosed |
| WO-1997003951-A1 | ESTERS AND AMIDES AS PLA2 INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-02-06 | — | — | WO | disclosed |
| EP-0741697-A1 | AMINO ACID DERIVATIVES AND THEIR USE AS PHOSPHOLIPASE A2 INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-11-13 | — | — | EP | disclosed |
| WO-1995034540-A1 | BENZOHETEROCYCLIC DERIVATIVES USEFUL AS VASOPRESSIN OR OXYTOCIN MODULATORS | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1995-12-21 | — | — | WO | disclosed |
| WO-1995019959-A1 | AMINO ACID DERIVATIVES AND THEIR USE AS PHOSPHOLIPASE A2 INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-07-27 | — | — | WO | disclosed |